EndoGRO media formulations have lower serum concentrations than standard endothelial cell culture media, yet have been shown to support endothelial cell growth rates that exceed other commercially available serum-containing media, while maintaining excellent cell morphology. In addition, the media have no phenol red or antimicrobials, which can cause cell stress and mask natural biological processes. 

EndoGRO human umbilical vein endothelial cells are cultured for only one passage before cryopreservation to ensure the highest viability and culture life. Growth of these cells is enhanced by the use of EndoGRO media. EndoGRO cells and media are part of Millipore’s expanding selection of specialty cell culture tools. More information is available at www.millipore.com/cellbiology.

About Millipore
Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge technologies, tools, and services for bioscience research and biopharmaceutical manufacturing. As a strategic partner, we collaborate with customers to confront the world’s challenging human health issues. From research to development to production, our scientific expertise and innovative solutions help customers tackle their most complex problems and achieve their goals. Millipore Corporation is an S&P 500 company with more than 5,900 employees worldwide. For more information, please contact Millipore Tech Service at 1-800-548-7853 or 951-676-8080 or visit www.millipore.com

ADVANCING LIFE SCIENCE TOGETHER^TM
Research. Development. Production.

Millipore Media Contact
Greg Hoff
Media Relations
Bioscience Division
978-762-5170
greg_hoff@millipore.com

Millipore is a registered trademark, and the “M” logo, EndoGRO, and ADVANCING LIFE SCIENCE TOGETHER are trademarks of Millipore Corporation.